115 related articles for article (PubMed ID: 15970701)
1. 53BP1 is a positive regulator of the BRCA1 promoter.
Rauch T; Zhong X; Pfeifer GP; Xu X
Cell Cycle; 2005 Aug; 4(8):1078-83. PubMed ID: 15970701
[TBL] [Abstract][Full Text] [Related]
2. c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells.
Chen Y; Xu J; Borowicz S; Collins C; Huo D; Olopade OI
BMC Cancer; 2011 Jun; 11():246. PubMed ID: 21668996
[TBL] [Abstract][Full Text] [Related]
3. Positive regulation of the BRCA1 promoter.
Thakur S; Croce CM
J Biol Chem; 1999 Mar; 274(13):8837-43. PubMed ID: 10085126
[TBL] [Abstract][Full Text] [Related]
4. A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency.
Signori E; Bagni C; Papa S; Primerano B; Rinaldi M; Amaldi F; Fazio VM
Oncogene; 2001 Jul; 20(33):4596-600. PubMed ID: 11494157
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of CpG methylation in the BRCA1 promoter region.
DiNardo DN; Butcher DT; Robinson DP; Archer TK; Rodenhiser DI
Oncogene; 2001 Aug; 20(38):5331-40. PubMed ID: 11536045
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
Baldwin RL; Nemeth E; Tran H; Shvartsman H; Cass I; Narod S; Karlan BY
Cancer Res; 2000 Oct; 60(19):5329-33. PubMed ID: 11034065
[TBL] [Abstract][Full Text] [Related]
8. Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1.
Zhou J; Hu G; Herring BP
Mol Cell Biol; 2005 Nov; 25(22):9874-85. PubMed ID: 16260603
[TBL] [Abstract][Full Text] [Related]
9. Regulation of BRCA1 expression and its relationship to sporadic breast cancer.
Mueller CR; Roskelley CD
Breast Cancer Res; 2003; 5(1):45-52. PubMed ID: 12559046
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
11. Germline alterations in the 53BP1 gene in breast and ovarian cancer families.
Rapakko K; Heikkinen K; Karppinen SM; Erkko H; Winqvist R
Cancer Lett; 2007 Jan; 245(1-2):337-40. PubMed ID: 16517057
[TBL] [Abstract][Full Text] [Related]
12. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
Chan KY; Ozçelik H; Cheung AN; Ngan HY; Khoo US
Cancer Res; 2002 Jul; 62(14):4151-6. PubMed ID: 12124354
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 regulates p53-dependent gene expression.
Ouchi T; Monteiro AN; August A; Aaronson SA; Hanafusa H
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2302-6. PubMed ID: 9482880
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of BRCA1 and BRCA2 in ovarian cancer.
Hilton JL; Geisler JP; Rathe JA; Hattermann-Zogg MA; DeYoung B; Buller RE
J Natl Cancer Inst; 2002 Sep; 94(18):1396-406. PubMed ID: 12237285
[TBL] [Abstract][Full Text] [Related]
16. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
18. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
[TBL] [Abstract][Full Text] [Related]
19. Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.
Ghimenti C; Sensi E; Presciuttini S; Brunetti IM; Conte P; Bevilacqua G; Caligo MA
Genes Chromosomes Cancer; 2002 Mar; 33(3):235-42. PubMed ID: 11807980
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.
Kontorovich T; Cohen Y; Nir U; Friedman E
Breast Cancer Res Treat; 2009 Jul; 116(1):195-200. PubMed ID: 18642075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
